TRPML
TRPML or Transient Receptor Potential Mucolipin is a group of proteins that belong to the larger family of Transient Receptor Potential (TRP) channels. These proteins are integral membrane proteins that function as ion channels. TRPML channels are primarily found in the membranes of lysosomes and late endosomes, and play a crucial role in the regulation of these organelles.
Function[edit]
TRPML channels are non-selective cation channels that primarily conduct calcium (Ca2+) and sodium (Na+) ions. They play a key role in the regulation of lysosomal and endosomal trafficking, fusion, and fission processes. These channels are also involved in the regulation of autophagy, a cellular degradation pathway that is essential for survival, differentiation, development, and homeostasis.
Structure[edit]
TRPML channels are composed of six transmembrane segments (S1-S6) with a pore loop between S5 and S6. The N- and C-termini of the protein are located in the cytoplasm. The channels are tetramers, with each subunit contributing to the ion-conducting pore.
Types[edit]
There are three known types of TRPML channels in humans: TRPML1, TRPML2, and TRPML3. Each type is encoded by a separate gene (MCOLN1, MCOLN2, and MCOLN3 respectively) and has distinct functional properties and tissue distribution.
TRPML1[edit]
TRPML1 is the most studied of the TRPML channels. Mutations in the MCOLN1 gene that encodes TRPML1 cause Mucolipidosis type IV, a severe neurodegenerative disease.
TRPML2[edit]
TRPML2 is less well characterized than TRPML1. It is thought to be involved in immune cell function.
TRPML3[edit]
TRPML3 is associated with the varitint-waddler phenotype in mice, which includes hearing loss, pigmentation defects, and sterility.
Clinical significance[edit]
Mutations in the genes encoding TRPML channels can lead to various diseases. As mentioned above, mutations in MCOLN1 cause Mucolipidosis type IV. Additionally, alterations in TRPML function have been implicated in a number of other diseases, including Parkinson's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, and Frontotemporal dementia.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian